[3H]205-501, a Non-catechol dopaminergic agonist, labels selectively and with high affinity dopamine D2 receptors
- 1 September 1985
- journal article
- research article
- Published by Springer Nature in Journal Of Neural Transmission-Parkinsons Disease and Dementia Section
- Vol. 62 (3-4) , 231-248
- https://doi.org/10.1007/bf01252239
Abstract
Summary [3H]205–501, a noncatechol dopaminergic agonist, is presented as a ligand with high affinity (KD ∼ 1 nM) and high selectivity for dopamine receptors. pKi values of dopaminergic agonists derived from competition isotherms in the [3H]205–501 binding assay correlate very well with their potency in the acetylcholine release assay, which is controlled by dopamine D2 receptors. There is however no correlation with their potency stimulating adenylate cyclase, a process controlled by dopamine D1 receptors. Thus [3H]205–501 is the first agonist ligand selective for dopamine D2 receptors.Keywords
This publication has 34 references indexed in Scilit:
- Octahydrobenzo[g]quinolines: potent dopamine agonists which show the relationship between ergolines and apomorphineJournal of Medicinal Chemistry, 1985
- Dopaminergic 3H-agonist receptors in rat brain new evidence on localization and pharmacologyLife Sciences, 1984
- Affinity spectra: A novel way for the evaluation of equilibrium binding experimentsNaunyn-Schmiedebergs Archiv für experimentelle Pathologie und Pharmakologie, 1983
- Use of [3H] Spiperone for Labelling Dopaminergic and Serotonergic Receptors in Bovine Caudate NucleusJournal of Neurochemistry, 1981
- 3-PPP, a new centrally acting DA-receptor agonist with selectivity for autoreceptorsLife Sciences, 1981
- Bremazocine: A potent, long-acting opiate kappa-agonistLife Sciences, 1980
- Two novel prolactin release-inhibiting 8α-amino-ergolinesCellular and Molecular Life Sciences, 1979
- Different kinetic properties of neuroleptic receptor binding in the rat striatum and frontal cortexLife Sciences, 1978
- A simple ultrasensitive method for the assay of cyclic AMP and cyclic GMP in tissuesLife Sciences, 1976
- Relationship between the inhibition constant (KI) and the concentration of inhibitor which causes 50 per cent inhibition (I50) of an enzymatic reactionBiochemical Pharmacology, 1973